Can GLP-1s prevent obesity-related cancer?
Research summary: Can GLP-1 agonists, like Ozempic, prevent obesity-related cancer?
Hi there!
This is Jing, founder of ALLSET.
In this newsletter extension, I summarise healthy ageing research the ALLSET team is looking at.
Featured Study
Incretin triple agonist retatrutide (LY3437943) alleviates obesity-associated cancer progression
DOI: 10.1038/s44324-025-00054-5
Key Finding
Keep reading with a 7-day free trial
Subscribe to ALLSET Gazette to keep reading this post and get 7 days of free access to the full post archives.